These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 19725511

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.
    Choi J, Govindaraj RG, Hyeon JW, Lee K, Ma S, Kim SY, Lee J, No KT.
    Chem Biol Drug Des; 2017 Jun; 89(6):907-917. PubMed ID: 27933736
    [Abstract] [Full Text] [Related]

  • 7. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S, Glockshuber R.
    J Mol Biol; 1996 Sep 06; 261(5):614-9. PubMed ID: 8800210
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Misfolding dynamics of human prion protein.
    Zaman MH.
    Mol Cell Biomech; 2005 Dec 06; 2(4):179-90. PubMed ID: 16705864
    [Abstract] [Full Text] [Related]

  • 10. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N, Weber P, Giese A, Kretzschmar H.
    Biochem Biophys Res Commun; 2005 Jan 14; 326(2):339-43. PubMed ID: 15582583
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S, Glockshuber R.
    Biochemistry; 1999 Mar 16; 38(11):3258-67. PubMed ID: 10079068
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ, DeMarco ML, Daggett V.
    Biochemistry; 2004 Oct 19; 43(41):12955-63. PubMed ID: 15476389
    [Abstract] [Full Text] [Related]

  • 18. Characterizing the denatured state of human prion 121-230.
    Lee CI, Chang NY.
    Biophys Chem; 2010 Sep 19; 151(1-2):86-90. PubMed ID: 20627399
    [Abstract] [Full Text] [Related]

  • 19. The elusive intermediate on the folding pathway of the prion protein.
    Jenkins DC, Sylvester ID, Pinheiro TJ.
    FEBS J; 2008 Mar 19; 275(6):1323-35. PubMed ID: 18279390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.